Quest Diagnostics: Q2 Earnings Insights

Quest Diagnostics (NYSE:DGX) reported its Q2 earnings results on Thursday, July 21, 2022 at 06:45 AM.

Here's what investors need to know about the announcement.

Quest Diagnostics beat estimated earnings by 7.27%, reporting an EPS of $2.36 versus an estimate of $2.2.

Revenue was down $97.00 million from the same period last year.

Last quarter the company beat on EPS by $0.25 which was followed by a 3.14% drop in the share price the next day.

Here's a look at Quest Diagnostics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	2.97	3.17	2.87	2.86
EPS Actual	3.22	3.33	3.96	3.18
Revenue Estimate	2.63B	2.66B	2.45B	2.38B
Revenue Actual	2.61B	2.74B	2.77B	2.55B

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Quest Diagnostics management provided guidance for FY 2022, expecting earnings between $9.55 and $9.95 per share.

To track all earnings releases for Quest Diagnostics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.